{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:22:11Z","timestamp":1771928531281,"version":"3.50.1"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Background: Metabolic associated fatty liver disease (MAFLD) represents a globally prevalent chronic hepatic disorder hallmarked by excessive lipid accumulation within hepatocytes. This condition can progressively deteriorate to cirrhosis and hepatocellular carcinoma, thereby imposing a substantial healthcare burden. Numerous laboratory studies confirm that drugs targeting the nuclear receptor (NR)-lipophagy axis exhibit preventive and therapeutic potential for MAFLD. However, most remain confined to animal and cell models, and no specific MAFLD therapies are clinically available. In contrast, traditional Chinese medicine (TCM) has garnered considerable interest due to its unique theoretical framework and clinical efficacy in MAFLD management. Purpose: This article systematically reviews existing herbal compounds, extracts, and active metabolites that target the NR-lipophagy interaction for MAFLD treatment. It aims to facilitate the development of low-side-effect herbal formulations and offer valuable insights for future research on the NR-lipophagy axis. Method: Search terms including \u201cMAFLD\u201d, \u201cnuclear receptor\u201d, \u201clipophagy\u201d, \u201cCompound Traditional Chinese Medicine\u201d, \u201cactive metabolites\u201d, \u201cnatural products\u201d, and \u201cdisease\u201d were combined for literature retrieval. Result: As modulators of pleiotropic NRs, certain herbal metabolites mimic endogenous ligands to exert regulatory lipolysis effects\u2014synergistically modulating lipid metabolism, mitigating oxidative stress, and suppressing inflammation during MAFLD intervention. Herbal compound preparations modulate the NR-lipophagy axis\n                    <jats:italic>via<\/jats:italic>\n                    multi-target, multi-pathway mechanisms: moderately activating fatty acid (FA) oxidation pathways while repressing lipogenesis, thereby achieving sustained amelioration of MAFLD. Conclusion: TCM (including herbal compound preparations, extracts, and active metabolites) exerts therapeutic effects on MAFLD by inducing lipophagy through diverse pharmacological mechanisms and NR-associated signaling pathways. These agents emerge as promising focal points for MAFLD basic research and potential candidates for MAFLD drug development, offering reduced side effects and enhanced therapeutic efficacy.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2025.1744069","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:45:50Z","timestamp":1770111950000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting lipophagy and nuclear receptors in metabolic-associated fatty liver disease: insights from traditional Chinese medicine"],"prefix":"10.3389","volume":"16","author":[{"given":"Ting","family":"Yue","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College of Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafei","family":"Huang","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College of Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Faculty of Chinese Medicine, Medical Sciences Division, Macau University of Science and Technology","place":["Macao, China"]},{"name":"State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology","place":["Macao, China"]},{"name":"Macau University of Science and Technology Zhuhai MUST Science and Technology Research Institute","place":["Zhuhai, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Yu","sequence":"additional","affiliation":[{"name":"Faculty of Chinese Medicine, Medical Sciences Division, Macau University of Science and Technology","place":["Macao, China"]},{"name":"State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology","place":["Macao, China"]},{"name":"Macau University of Science and Technology Zhuhai MUST Science and Technology Research Institute","place":["Zhuhai, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"He","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College of Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Yu","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College of Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College of Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","article-title":"FXR agonists in NASH treatment","volume":"79","author":"Adorini","year":"2023","journal-title":"J. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.jhep.2019.06.011","article-title":"Obeticholic acid may increase the risk of gallstone formation in susceptible patients","volume":"71","author":"Al-Dury","year":"2019","journal-title":"J. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jhep.2019.01.026","article-title":"Autophagy in liver diseases: time for translation?","volume":"70","author":"Allaire","year":"2019","journal-title":"J. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cld.2023.01.019","article-title":"Hepatic outcomes of Nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma","volume":"27","author":"Alqahtani","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2217\/nnm-2022-0261","article-title":"Nanodrug delivery systems for metabolic chronic liver diseases: advances and perspectives","volume":"18","author":"Athanasopoulou","year":"2023","journal-title":"Nanomedicine (Lond)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/liv.15139","article-title":"Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: focusing on the non-overlap groups","volume":"42","author":"Ayada","year":"2022","journal-title":"Liver Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E292","DOI":"10.1152\/ajpendo.00638.2020","article-title":"Estrogen-wnt signaling cascade regulates expression of hepatic fibroblast growth factor 21","volume":"321","author":"Badakhshi","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cmet.2013.04.021","article-title":"Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance","volume":"18","author":"Beaven","year":"2013","journal-title":"Cell Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1194\/jlr.M900096","article-title":"Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice","volume":"51","author":"Bischoff","year":"2010","journal-title":"J. Lipid Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s00125-005-0105-3","article-title":"Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver","volume":"49","author":"Bryzgalova","year":"2006","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1111\/bph.15286","article-title":"Screening for liver X receptor modulators: where are we and for what use?","volume":"178","author":"Bu\u00f1ay","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm3312","article-title":"Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR","volume":"13","author":"Calkin","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"42530","DOI":"10.18632\/oncotarget.6466","article-title":"Oleoylethanolamide, an endogenous PPAR-\u03b1 ligand, attenuates liver fibrosis targeting hepatic stellate cells","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","first-page":"152896","DOI":"10.1016\/j.phymed.2019.152896","article-title":"Selection and evaluation of quality markers from Yinlan capsule and its LXR\u03b1-mediated therapy for hyperlipidemia","volume":"59","author":"Chen","year":"2019","journal-title":"Phytomedicine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrendo.2015.205","article-title":"Nongenomic actions of thyroid hormone","volume":"12","author":"Davis","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bbalip.2016.12.007","article-title":"Regulation of SREBP-2 intracellular trafficking improves impaired autophagic flux and alleviates endoplasmic reticulum stress in NAFLD","volume":"1862","author":"Deng","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"B19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s11658-024-00631-4","article-title":"Paeoniflorin protects hepatocytes from APAP-induced damage through launching autophagy via the MAPK\/mTOR signaling pathway","volume":"29","author":"Deng","year":"2024","journal-title":"Cell Mol. Biol. Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fphar.2019.00266","article-title":"A combined phytochemistry and network pharmacology approach to reveal the potential antitumor effective substances and mechanism of Phellinus igniarius","volume":"10","author":"Dong","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/jci23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1016\/j.apsb.2021.12.012","article-title":"Nuciferine protects against high-fat diet-induced hepatic steatosis and insulin resistance via activating TFEB-mediated autophagy-lysosomal pathway","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B23","doi-asserted-by":"publisher","first-page":"15490","DOI":"10.1073\/pnas.0702759104","article-title":"Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index","volume":"104","author":"Erion","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol. Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"156016","DOI":"10.1016\/j.phymed.2024.156016","article-title":"Multi-omics analysis provides new insights into mechanism of didymin on non-alcoholic fatty liver disease in rats","volume":"135","author":"Fang","year":"2024","journal-title":"Phytomedicine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s12072-024-10704-3","article-title":"Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease","volume":"18","author":"Fouad","year":"2024","journal-title":"Hepatol. Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.3390\/cells11193153","article-title":"TFEB; beyond its role as an autophagy and lysosomes regulator","volume":"11","author":"Franco-Ju\u00e1rez","year":"2022","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPAR\u03b1 gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis","volume":"63","author":"Francque","year":"2015","journal-title":"J. Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.3390\/nu14112187","article-title":"The role of phytosterols in nonalcoholic fatty liver disease","volume":"14","author":"Frasinariu","year":"2022","journal-title":"Nutrients"},{"key":"B30","doi-asserted-by":"publisher","first-page":"154219","DOI":"10.1016\/j.phymed.2022.154219","article-title":"Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPAR\u03b1 and INSIG\/SREBP1c pathway","volume":"103","author":"Gu","year":"2022","journal-title":"Phytomedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12876-016-0568-3","article-title":"Relevance of FXR-p62\/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis","volume":"17","author":"Haga","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e5522","DOI":"10.7717\/peerj.5522","article-title":"Effects of resveratrol, exercises and their combination on farnesoid X receptor, liver X receptor and Sirtuin 1 gene expression and apoptosis in the liver of elderly rats with nonalcoholic fatty liver","volume":"6","author":"Hajighasem","year":"2018","journal-title":"PeerJ"},{"key":"B33","doi-asserted-by":"publisher","first-page":"108794","DOI":"10.1016\/j.cbi.2019.108794","article-title":"Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR\/LXRs-dependent manner","volume":"311","author":"Han","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"B34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/1074248410362891","article-title":"Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100\/human CETP transgenic mice","volume":"15","author":"Hansen","year":"2010","journal-title":"J. Cardiovasc Pharmacol. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1530\/jme-16-0139","article-title":"ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis","volume":"57","author":"He","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1872-034X.2008.00382.x","article-title":"Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease","volume":"38","author":"Higuchi","year":"2008","journal-title":"Hepatol. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1210\/me.2002-0399","article-title":"Liver X receptors interact with corepressors to regulate gene expression","volume":"17","author":"Hu","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1139\/apnm-2019-0057","article-title":"Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPAR\u03b1 pathway","volume":"45","author":"Huang","year":"2020","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev-pharmtox-010611-134537","article-title":"AMPK and mTOR in cellular energy homeostasis and drug targets","volume":"52","author":"Inoki","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.taap.2013.04.023","article-title":"Resveratrol inhibits LXR\u03b1-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction","volume":"271","author":"Jin","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.3390\/nu16244282","article-title":"The effect of quercetin on non-alcoholic fatty liver disease (NAFLD) and the role of Beclin1, P62, and LC3: an experimental study","volume":"16","author":"Katsaros","year":"2024","journal-title":"Nutrients"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/hep.22187","article-title":"Impaired autophagy: a mechanism of mitochondrial dysfunction in anoxic rat hepatocytes","volume":"47","author":"Kim","year":"2008","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/cells12091292","article-title":"Targeting liver X receptors for the treatment of non-alcoholic fatty liver disease","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"B44","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.bbrc.2015.10.052","article-title":"An SOD1 deficiency enhances lipid droplet accumulation in the fasted mouse liver by aborting lipophagy","volume":"467","author":"Kurahashi","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13020-021-00434-1","article-title":"Hepatoprotective effect of qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat","volume":"16","author":"Lan","year":"2021","journal-title":"Chin. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/molecules25071580","article-title":"Modulation of the autophagy-lysosomal pathway in hepatocellular carcinoma using small molecules","volume":"25","author":"Lee","year":"2020","journal-title":"Molecules"},{"key":"B47","doi-asserted-by":"publisher","first-page":"549101","DOI":"10.1155\/2010\/549101","article-title":"AMPK-dependent metabolic regulation by PPAR agonists","volume":"2010","author":"Lee","year":"2010","journal-title":"PPAR Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature13961","article-title":"Nutrient-sensing nuclear receptors coordinate autophagy","volume":"516","author":"Lee","year":"2014","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","article-title":"Biological functions of autophagy genes: a disease perspective","volume":"176","author":"Levine","year":"2019","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.tem.2019.05.007","article-title":"Going back to the biology of FGF21: new insights","volume":"30","author":"Lewis","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"114933","DOI":"10.1016\/j.bcp.2022.114933","article-title":"Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease","volume":"197","author":"Li","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.mce.2014.10.028","article-title":"Botanical compounds and their regulation of nuclear receptor action: the case of traditional Chinese medicine","volume":"401","author":"Li","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e1601470","DOI":"10.1126\/sciadv.1601470","article-title":"A novel Rab10-EHBP1-EHD2 complex essential for the autophagic engulfment of lipid droplets","volume":"2","author":"Li","year":"2016","journal-title":"Sci. Adv."},{"key":"B54","doi-asserted-by":"publisher","first-page":"632","DOI":"10.2174\/1871530319666190207163325","article-title":"Silibinin ameliorates fructose-induced lipid accumulation and activates autophagy in HepG2 cells","volume":"19","author":"Li","year":"2019","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"B55","doi-asserted-by":"publisher","first-page":"108179","DOI":"10.1016\/j.jbc.2025.108179","article-title":"The steroid hormone 20-hydroxyecdysone induces lipophagy via the brain-adipose tissue axis by promoting the adipokinetic hormone pathway","volume":"301","author":"Li","year":"2025","journal-title":"J. Biol. Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1507\/endocrj.k10e-043","article-title":"Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXR\u03b1 and PPAR\u03b1 transcriptional programs","volume":"57","author":"Liu","year":"2010","journal-title":"Endocr. J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"118841","DOI":"10.1016\/j.jep.2024.118841","article-title":"Systematic pharmacology and experimental validation to elucidate the inflammation-associated mechanism of huanglian wendan (HLWD) decoction in the treatment of MAFLD associated with atherosclerosis","volume":"337","author":"Liu","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1124\/molpharm.124.000889","article-title":"The estrogen receptor-related orphan receptors regulate autophagy through TFEB","volume":"106","author":"Losby","year":"2024","journal-title":"Mol. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/cmdc.201400009","article-title":"Design, synthesis, and activity evaluation of GK\/PPAR\u03b3 dual-target-directed ligands as hypoglycemic agents","volume":"9","author":"Lu","year":"2014","journal-title":"ChemMedChem"},{"key":"B62","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12915-014-0082-4","article-title":"Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy","volume":"12","author":"Luengo","year":"2014","journal-title":"BMC Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"ra9","DOI":"10.1126\/scisignal.2004754","article-title":"The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris","volume":"7","author":"Martina","year":"2014","journal-title":"Sci. Signal"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3390\/ph16111631","article-title":"Quercetin as a therapeutic product: evaluation of its pharmacological action and clinical Applications-A review","volume":"16","author":"Mirza","year":"2023","journal-title":"Pharm. (Basel)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/s0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"B68","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s40264-019-00810-9","article-title":"Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation","volume":"42","author":"Nguyen","year":"2019","journal-title":"Drug Saf."},{"key":"B69","doi-asserted-by":"publisher","first-page":"465282","DOI":"10.1155\/2012\/465282","article-title":"Metformin stimulates FGF21 expression in primary hepatocytes","volume":"2012","author":"Nygaard","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1194\/jlr.M069013","article-title":"Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female mice","volume":"57","author":"Palmisano","year":"2016","journal-title":"J. Lipid Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"155712","DOI":"10.1016\/j.phymed.2024.155712","article-title":"Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats","volume":"130","author":"Pan","year":"2024","journal-title":"Phytomedicine"},{"key":"B72","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/15548627.2016.1140293","article-title":"The ULK1 complex mediates MTORC1 signaling to the autophagy initiation machinery via binding and phosphorylating ATG14","volume":"12","author":"Park","year":"2016","journal-title":"Autophagy"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1038\/emboj.2011.257","article-title":"Regulation of TFEB and V-ATPases by mTORC1","volume":"30","author":"Pe\u00f1a-Llopis","year":"2011","journal-title":"Embo J."},{"key":"B75","doi-asserted-by":"publisher","first-page":"612089","DOI":"10.1155\/2010\/612089","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"2010","author":"Rakhshandehroo","year":"2010","journal-title":"PPAR Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e202208092","DOI":"10.1083\/jcb.202208092","article-title":"NBR1: the archetypal selective autophagy receptor","volume":"221","author":"Rasmussen","year":"2022","journal-title":"J. Cell Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2337\/db08-0176","article-title":"Activation of peroxisome proliferator-activated receptor beta\/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1\/2","volume":"57","author":"Rodr\u00edguez-Calvo","year":"2008","journal-title":"Diabetes"},{"key":"B78","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1152\/physiolgenomics.00127.2009","article-title":"Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta\/delta in regulation of gene expression in mouse liver","volume":"41","author":"Sanderson","year":"2010","journal-title":"Physiol. Genomics"},{"key":"B79","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1152\/ajpendo.00129.2018","article-title":"Growth hormone acts along the PPAR\u03b3-FSP27 axis to stimulate lipolysis in human adipocytes","volume":"316","author":"Sharma","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B80","doi-asserted-by":"publisher","first-page":"114340","DOI":"10.1016\/j.jep.2021.114340","article-title":"Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway","volume":"279","author":"Shen","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"E886","DOI":"10.1152\/ajpendo.00332.2010","article-title":"Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice","volume":"300","author":"Sheng","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B82","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm3757","article-title":"Making new contacts: the mTOR network in metabolism and signalling crosstalk","volume":"15","author":"Shimobayashi","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1074\/jbc.M115.668673","article-title":"Hepatic FOXO1 target genes are Co-regulated by thyroid hormone via RICTOR protein deacetylation and MTORC2-AKT protein inhibition","volume":"291","author":"Singh","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B85","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/bcpt.13190","article-title":"A role of peroxisome proliferator-activated receptor \u03b3 in non-alcoholic fatty liver disease","volume":"124","author":"Skat-R\u00f8rdam","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of nonalcoholic fatty liver disease: role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B87","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.molcel.2017.07.003","article-title":"Vps34 kinase domain dynamics regulate the Autophagic PI 3-Kinase complex","volume":"67","author":"Stjepanovic","year":"2017","journal-title":"Mol. Cell"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/15548627.2015.1072670","article-title":"VDR\/vitamin D receptor regulates autophagic activity through ATG16L1","volume":"12","author":"Sun","year":"2016","journal-title":"Autophagy"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1038\/s41467-018-05254-w","article-title":"An autophagy assay reveals the ESCRT-III component CHMP2A as a regulator of phagophore closure","volume":"9","author":"Takahashi","year":"2018","journal-title":"Nat. Commun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.3390\/ijms19123812","article-title":"AMPK: regulation of metabolic dynamics in the context of autophagy","volume":"19","author":"Tamargo-G\u00f3mez","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/hep.28820","article-title":"Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice","volume":"64","author":"Tanaka","year":"2016","journal-title":"Hepatology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41419-019-1458-8","article-title":"PPAR\u03b4 attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation","volume":"10","author":"Tong","year":"2019","journal-title":"Cell Death Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1080\/10408398.2014.952399","article-title":"The potential of flavonoids in the treatment of non-alcoholic fatty liver disease","volume":"57","author":"Van De Wier","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B94","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41580-022-00542-2","article-title":"The mechanisms and roles of selective autophagy in mammals","volume":"24","author":"Vargas","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1080\/10408398.2018.1540969","article-title":"Impact of plant extracts upon human health: a review","volume":"60","author":"Veiga","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3390\/cells9112367","article-title":"The role of PPARs in disease","volume":"9","author":"Wagner","year":"2020","journal-title":"Cells"},{"key":"B97","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.molcel.2018.09.017","article-title":"mTORC1-regulated and HUWE1-mediated WIPI2 degradation controls autophagy flux","volume":"72","author":"Wan","year":"2018","journal-title":"Mol. Cell"},{"key":"B98","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling and membrane homeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"B99","first-page":"1748","article-title":"Study of HPLC-DAD fingerprint on complex traditional Chinese medicine proprietary preparation-Baoji pills","volume":"32","author":"Wang","year":"2007","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B100","doi-asserted-by":"publisher","first-page":"10184","DOI":"10.1021\/acs.jafc.1c04298","article-title":"Microbial phosphorylation product of hesperetin by Bacillus subtilis BCRC 80517 improves oral bioavailability in rats","volume":"69","author":"Wang","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"B101","doi-asserted-by":"publisher","first-page":"155192","DOI":"10.1016\/j.phymed.2023.155192","article-title":"QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver","volume":"123","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e70524","DOI":"10.1111\/jcmm.70524","article-title":"Berberine attenuates nonalcoholic hepatic steatosis by regulating lipid droplet-associated proteins: in vivo, in vitro and molecular evidence","volume":"29","author":"Wang","year":"","journal-title":"J. Cell Mol. Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3390\/ph18111707","article-title":"The ErChen decoction and its active compounds ameliorate non-alcoholic fatty liver disease through activation of the AMPK signaling pathway","volume":"18","author":"Wang","year":"","journal-title":"Pharm. (Basel)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1172\/jci21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1039\/d2tb00225f","article-title":"Nano-traditional Chinese medicine: a promising strategy and its recent advances","volume":"10","author":"Wei","year":"2022","journal-title":"J. Mater Chem. B"},{"key":"B106","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.semcancer.2013.05.007","article-title":"Autophagosome formation--the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage","volume":"23","author":"Wirth","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.apsb.2019.10.003","article-title":"Targeting autophagy-related protein kinases for potential therapeutic purpose","volume":"10","author":"Xiang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.19540\/j.cnki.cjcmm.20250212.501","article-title":"Jianpi qinghua formula improves metabolic-associated fatty liver disease by modulating PGC1\u03b1\/PPAR\u03b1\/CPT1A pathway","volume":"50","author":"Xiao","year":"2025","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B110","doi-asserted-by":"publisher","first-page":"940","DOI":"10.19852\/j.cnki.jtcm.2022.06.007","article-title":"Effect of Dangfei Liganning capsule on liver X receptor \u03b1\/steroid regulatory element binding protein-1\/fatty acid synthase signal pathway in rats with metabolic-associated fatty liver disease","volume":"42","author":"Xiaoling","year":"2022","journal-title":"J. Tradit. Chin. Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.7150\/ijbs.62556","article-title":"Berberine modulates deacetylation of PPAR\u03b3 to promote adipose tissue remodeling and thermogenesis via AMPK\/SIRT1 pathway","volume":"17","author":"Xu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"B113","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11655-012-1023-0","article-title":"Ping-tang recipe improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats","volume":"18","author":"Yang","year":"2012","journal-title":"Chin. J. Integr. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ptr.6486","article-title":"Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db\/db mice","volume":"33","author":"Yang","year":"2019","journal-title":"Phytother. Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1186\/s12967-023-04790-4","article-title":"Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis","volume":"21","author":"Yang","year":"2023","journal-title":"J. Transl. Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-024-05060-7","article-title":"Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK\/PGC-1\u03b1 and PPAR\u03b1-mediated autophagy pathway","volume":"22","author":"Yang","year":"2024","journal-title":"J. Transl. Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"157272","DOI":"10.1016\/j.phymed.2025.157272","article-title":"Research progress on the pharmacological properties of active ingredients from Salvia miltiorrhiza: a review","volume":"148","author":"Yang","year":"2025","journal-title":"Phytomedicine"},{"key":"B118","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbrc.2018.11.076","article-title":"Each liver X receptor (LXR) type has a different purpose in different situations","volume":"508","author":"Yonezawa","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B119","doi-asserted-by":"publisher","first-page":"146973","DOI":"10.1016\/j.gene.2022.146973","article-title":"Yin-Chen Wu-Ling powder alleviate cholestatic liver disease: network pharmacological analysis and experimental validation","volume":"851","author":"You","year":"2023","journal-title":"Gene"},{"key":"B120","doi-asserted-by":"publisher","first-page":"118165","DOI":"10.1016\/j.jep.2024.118165","article-title":"Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways","volume":"329","author":"You","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/s0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"B122","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molmet.2017.12.008","article-title":"Hepatic regulation of VLDL receptor by PPAR\u03b2\/\u03b4 and FGF21 modulates non-alcoholic fatty liver disease","volume":"8","author":"Zarei","year":"2018","journal-title":"Mol. Metab."},{"key":"B123","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.lfs.2018.07.018","article-title":"Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-\u03baB-mediated autophagy activation","volume":"208","author":"Zhai","year":"2018","journal-title":"Life Sci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/mnfr.201500016","article-title":"Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway","volume":"59","author":"Zhang","year":"","journal-title":"Mol. Nutr. Food Res."},{"key":"B125","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cyto.2015.05.031","article-title":"PPAR\u03b1\/\u03b3 agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats","volume":"75","author":"Zhang","year":"","journal-title":"Cytokine"},{"key":"B126","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1111\/bph.14482","article-title":"Nuciferine ameliorates hepatic steatosis in high-fat diet\/streptozocin-induced diabetic mice through a PPAR\u03b1\/PPAR\u03b3 coactivator-1\u03b1 pathway","volume":"175","author":"Zhang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.2147\/dddt.S258187","article-title":"Galangin improved non-alcoholic fatty liver disease in mice by promoting autophagy","volume":"14","author":"Zhang","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"B128","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41419-022-04593-3","article-title":"The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.2147\/dddt.S417378","article-title":"Si-Ni-San reduces hepatic lipid deposition in rats with metabolic associated fatty liver disease by AMPK\/SIRT1 pathway","volume":"17","author":"Zhang","year":"2023","journal-title":"Drug Des. Devel Ther."},{"key":"B130","doi-asserted-by":"publisher","first-page":"21548","DOI":"10.1021\/acs.jafc.4c03172","article-title":"Astragaloside I promotes lipophagy and mitochondrial biogenesis to improve hyperlipidemia by regulating Akt\/mTOR\/TFEB pathway","volume":"72","author":"Zhao","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"B131","doi-asserted-by":"publisher","first-page":"114957","DOI":"10.1016\/j.biopha.2023.114957","article-title":"Hepatoprotective effect of typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro","volume":"164","author":"Zheng","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B132","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.intimp.2018.03.036","article-title":"Micheliolide alleviates hepatic steatosis in Db\/db mice by inhibiting inflammation and promoting autophagy via PPAR-\u03b3-mediated NF-\u043aB and AMPK\/mTOR signaling","volume":"59","author":"Zhong","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/medicines6010014","article-title":"Current status and major challenges to the safety and efficacy presented by Chinese herbal medicine","volume":"6","author":"Zhou","year":"2019","journal-title":"Med. (Basel)"},{"key":"B134","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11010-016-2774-2","article-title":"FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy","volume":"420","author":"Zhu","year":"2016","journal-title":"Mol. Cell Biochem."},{"key":"B135","doi-asserted-by":"publisher","first-page":"123570","DOI":"10.1016\/j.jchromb.2022.123570","article-title":"Identification of Yinchenwuling Fang\u2019s active components and hepatoprotective effects against cholestatic liver damage induced by alpha-naphthyl isothiocyanate in mice","volume":"1215","author":"Zou","year":"2023","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1744069\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:30:53Z","timestamp":1771925453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1744069\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":134,"alternative-id":["10.3389\/fphar.2025.1744069"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1744069","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"article-number":"1744069"}}